Nexalin Technology Inc.

NXL | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.63

+$0.36 (+8.43%)

At close: Sep 22, 2026, 4:00 PM ET

$4.63

$0 (0.00%)

After-hours: Sep 22, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+8.43%

(1D)

Rating

Updated: Sep 1, 2026

Fundamentals Weak

Market Sentiment Bullish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $3.4M

1D Range

4.31 4.63

52W Range

4 60

Valuation (TTM)

PE -0.30

PB 2.06

EV/EBITDA -0.24

Valuation (NTM)

Forward PE N/A

Forward PEG 0.02

Price Target N/A

Cash Flow

FCF Yield -198.3%

SBC Adj. FCF Yield -272.4%

SBC Impact -37.4%

Margins

Gross Margin -148.4%

Operating Margin -4202.5%

FCF Margin -2860.5%

Growth (CAGR)

Revenue 3Y | 5Y -30.6% | 10.2%

Dil EPS 3Y | 5Y 18.3% | -2.5%

FCF 3Y | 5Y -24.4% | -27.2%

Returns

ROA -299.2%

ROE -278.3%

ROIC -600.6%

Financial Health

Net Cash

$1M

Current Ratio 1.25

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Nexalin Technology, Inc. operates as a medical device firm specializing in the creation and advancement of neurostimulation therapies for mental health conditions in both the United States and China. ...

Sector Healthcare

Industry Medical - Devices

Employees 8

IPO Date Sep 15, 2022

Website www.nexalin.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Dec 2, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞